1. Home
  2. ALT vs EAD Comparison

ALT vs EAD Comparison

Compare ALT & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • EAD
  • Stock Information
  • Founded
  • ALT 1997
  • EAD 2003
  • Country
  • ALT United States
  • EAD United States
  • Employees
  • ALT N/A
  • EAD N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • EAD Finance/Investors Services
  • Sector
  • ALT Health Care
  • EAD Finance
  • Exchange
  • ALT Nasdaq
  • EAD Nasdaq
  • Market Cap
  • ALT 472.3M
  • EAD 400.1M
  • IPO Year
  • ALT N/A
  • EAD N/A
  • Fundamental
  • Price
  • ALT $5.40
  • EAD $6.84
  • Analyst Decision
  • ALT Strong Buy
  • EAD
  • Analyst Count
  • ALT 7
  • EAD 0
  • Target Price
  • ALT $21.00
  • EAD N/A
  • AVG Volume (30 Days)
  • ALT 2.5M
  • EAD 178.9K
  • Earning Date
  • ALT 05-13-2025
  • EAD 01-01-0001
  • Dividend Yield
  • ALT N/A
  • EAD 8.91%
  • EPS Growth
  • ALT N/A
  • EAD N/A
  • EPS
  • ALT N/A
  • EAD N/A
  • Revenue
  • ALT $20,000.00
  • EAD N/A
  • Revenue This Year
  • ALT $4,108.32
  • EAD N/A
  • Revenue Next Year
  • ALT $3,900.06
  • EAD N/A
  • P/E Ratio
  • ALT N/A
  • EAD N/A
  • Revenue Growth
  • ALT N/A
  • EAD N/A
  • 52 Week Low
  • ALT $3.55
  • EAD $5.69
  • 52 Week High
  • ALT $11.16
  • EAD $6.81
  • Technical
  • Relative Strength Index (RSI)
  • ALT 52.71
  • EAD 61.58
  • Support Level
  • ALT $5.38
  • EAD $6.68
  • Resistance Level
  • ALT $5.81
  • EAD $6.84
  • Average True Range (ATR)
  • ALT 0.35
  • EAD 0.06
  • MACD
  • ALT -0.03
  • EAD 0.00
  • Stochastic Oscillator
  • ALT 34.18
  • EAD 100.00

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About EAD Allspring Income Opportunities Fund

Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.

Share on Social Networks: